Go Pro

AdvisorShares Psychedelics ETF (PSIL) Holdings List

AdvisorShares Psychedelics ETF logo
$24.05 -1.00 (-3.99%)
Closing price 09/23/2026 04:10 PM Eastern
Extended Trading
$24.06 +0.00 (+0.02%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

What stocks does PSIL hold?

The AdvisorShares Psychedelics ETF (PSIL) top stock holdings include Compass Pathways, Definium Therapeutics, and Cybin Inc.. The top 25 PSIL holdings ordered by weight make up 99.69% of the total fund. PSIL is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete PSIL stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PSIL Holdings

RankCompanyCurrent PriceWeightShares Held
1
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
$13.75
-7.0%
12.28%477,715
2
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
$37.65
-6.6%
10.58%159,608
3Cybin Inc.N/A9.12%379,702
4Blackrock Treasury Trust Instl 62N/A7.89%4,606,531
5
Neuronetics, Inc. stock logo
STIM
Neuronetics
$2.88
-1.0%
4.91%964,380
6
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
$3.16
-4.8%
4.68%805,066
7
GH Research PLC stock logo
GHRS
GH Research
$25.96
-6.8%
4.58%93,067
8
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$139.49
-1.9%
4.46%17,164
9
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
$3.78
-10.8%
4.46%619,861
10
AbbVie Inc. stock logo
ABBV
AbbVie
$265.43
+0.1%
4.30%9,498
11
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$27.48
-10.7%
4.23%79,622
12
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$269.01
-0.1%
4.00%8,636
13Bright Minds Biosciences Inc.N/A3.99%37,822
14
Alkermes plc stock logo
ALKS
Alkermes
$42.13
-2.7%
3.61%45,071
15
Supernus Pharmaceuticals, Inc. stock logo
SUPN
Supernus Pharmaceuticals
$43.39
-0.8%
2.67%36,355
16Quantum BioPharma Ltd.N/A2.55%400,378
17
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,153.69
-1.4%
2.55%1,292
18
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
$6.31
+3.4%
2.26%208,538
19Optimi Health CorpN/A2.03%238,713
20
Neuphoria Therapeutics Inc. stock logo
NEUP
Neuphoria Therapeutics
$3.68
-1.3%
1.99%312,895
21
Pasithea Therapeutics Corp. stock logo
KTTA
Pasithea Therapeutics
$0.51
-0.3%
1.01%1,160,050
22
Incannex Healthcare Inc. stock logo
IXHL
Incannex Healthcare
$3.44
+1.5%
0.46%75,286
23Numinus Wellness Inc.N/A0.42%10,495,173
24
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.29
+1.1%
0.38%839,481
25
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
$1.77
+2.9%
0.28%93,472

PSIL Geographic Exposure

PSIL's largest geographic exposure is United States at 56.5%, followed by Canada at 24.4%.

  • United States
    56.5%
  • Canada
    24.4%
  • Ireland
    8.0%

PSIL Currency Exposure

PSIL is predominantly exposed to USD at 99.7%, followed by CAD at 0.5%.

  • USD
    99.7%
  • CAD
    0.5%

PSIL Sector Exposure

PSIL's largest sector exposure is Health Care at 67.6%, followed by Consumer Discretionary at 4.8%.

  • Health Care
    67.6%
  • Consumer Discretionary
    4.8%

PSIL Industry Exposure

PSIL's largest industry exposure is Biotechnology at 44.3%, followed by Pharmaceuticals at 22.8%.

  • Biotechnology
    44.3%
  • Pharmaceuticals
    22.8%
  • Diversified Consumer Services
    4.8%
  • Health Care Providers & Services
    0.5%

PSIL Sub-Industry Exposure

PSIL's largest sub-industry exposure is Biotechnology at 43.9%, followed by Pharmaceuticals at 23.2%.

  • Biotechnology
    43.9%
  • Pharmaceuticals
    23.2%
  • Health Care Equipment
    4.8%
  • Health Care Facilities
    0.5%

PSIL Coupon Exposure

PSIL's largest coupon exposure is 2-4 at 2.6%.

  • 2-4
    2.6%

Related Companies and Tools


MarketBeat tracks AdvisorShares Psychedelics ETF holdings and portfolio composition, last updated on 9/21/2026.
From Our Partners